The Pharmacy Times® Brain Health Resource Center is a comprehensive resource for clinical news and expert insights on issues related to neural development, plasticity, functioning, and recovery associated with aging.
May 28th 2025
Integrated health system specialty pharmacies can improve patient care for non–multiple sclerosis neurologic conditions.
Human-Specific Genes Can Modify Expressions of Mutations That Lead to Neurodevelopmental Disorders
October 29th 2024The investigators found that the SRGAP2 and SYNGAP1 genes act together to control the speed of human synapse development, which has impacts on neurodevelopmental disease pathways.
Read More
FDA Approves Sodium Oxybate to Treat Cataplexy or EDS in Pediatric Patients With Narcolepsy
Published: October 17th 2024 | Updated: October 17th 2024Patients aged 7 years and older can now be treated for their cataplexy or excessive daytime sleepiness with the extended-release oral formulation.
Read More
FDA Approves Foscarbidopa/Foslevodopa for Motor Fluctuations in Adults With Parkinson Disease
Published: October 17th 2024 | Updated: October 17th 2024This approval makes foscarbidopa/foslevodopa the first and only subcutaneous 24-hour infusion of levodopa-based therapy for adults with Parkinson disease.
Read More